Monika Wołosik; Natalia Bednarczyk; Rafał Bednarczyk; Radosław Krzysztof Binkowski; Agnieszka Kurek; Natalia Krajewska; Aleksandra Lejman; Aleksandra Mazurkiewicz; Hubert Sidor; Szymon Zysiak. COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. IJITSS 2026, 1 (1(49). https://doi.org/10.31435/ijitss.1(49).2026.4695.